| Sample | Group (Ӏ)* | Group (ӀӀ)* | |||||||||||||
| CaMV 35S | NOS | Ze in | β-globin | Cry1A.105 | Cry2Ab2 | Cry3Bb1 | CaMV 35S | NOS | Zein | β-globin | Cry1A.105 | Cry2Ab2 | Cry3Bb1 | ||
| Negative control | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | |
| Positive control | + | + | + | ‒ | + | + | + | + | + | + | ‒ | + | + | + | |
| ZFEs, Group Ӏ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | |
| ZFEs, Group ӀӀ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | ‒ | ‒ | ‒ | + | ‒ | ‒ | ‒ | |